V
ELV icon

Veritable’s Elevance Health ELV Stock Holding History

Veritable’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,582
Closed -$3.81M – 251
2023
Q2 		$3.81M Sell
8,582
-435
-5% -$201K 0.06% 148
2023
Q1 		$4.15M Buy
9,017
+62
+0.7% +$29.5K 0.07% 147
2022
Q4 		$4.59M Buy
8,955
+76
+0.9% +$38.6K 0.08% 127
2022
Q3 		$4.03M Sell
8,879
-1,430
-14% -$684K 0.08% 134
2022
Q2 		$4.97M Buy
10,309
+222
+2% +$110K 0.09% 121
2022
Q1 		$4.96M Buy
10,087
+1,714
+20% +$783K 0.08% 140
2021
Q4 		$3.88M Sell
8,373
-273
-3% -$115K 0.06% 165
2021
Q3 		$3.22M Sell
8,646
-11
-0.1% -$4.18K 0.05% 176
2021
Q2 		$3.31M Buy
8,657
+318
+4% +$122K 0.05% 174
2021
Q1 		$2.99M Buy
8,339
+239
+3% +$76.9K 0.05% 169
2020
Q4 		$2.6M Sell
8,100
-1,596
-16% -$490K 0.05% 180
2020
Q3 		$2.6M Sell
9,696
-9
-0.1% -$2.42K 0.05% 168
2020
Q2 		$2.55M Sell
9,705
-698
-7% -$186K 0.06% 156
2020
Q1 		$2.36M Sell
10,403
-407
-4% -$111K 0.06% 163
2019
Q4 		$3.27M Sell
10,810
-181
-2% -$49.8K 0.06% 169
2019
Q3 		$2.64M Buy
10,991
+54
+0.5% +$14.8K 0.05% 181
2019
Q2 		$3.09M Buy
10,937
+106
+1% +$29K 0.06% 162
2019
Q1 		$3.11M Buy
10,831
+81
+0.8% +$23.4K 0.06% 160
2018
Q4 		$2.82M Sell
10,750
-107
-1% -$29.4K 0.06% 161
2018
Q3 		$2.98M Sell
10,857
-247
-2% -$64.1K 0.06% 166
2018
Q2 		$2.64M Sell
11,104
-189
-2% -$43.8K 0.06% 169
2018
Q1 		$2.48M Sell
11,293
-294
-3% -$69.1K 0.05% 179
2017
Q4 		$2.61M Buy
11,587
+315
+3% +$67.1K 0.05% 179
2017
Q3 		$2.14M Buy
11,272
+5
+0% +$952 0.05% 216
2017
Q2 		$2.12M Buy
11,267
+486
+5% +$87.3K 0.05% 211
2017
Q1 		$1.78M Buy
10,781
+35
+0.3% +$5.57K 0.04% 229
2016
Q4 		$1.54M Buy
10,746
+487
+5% +$65.2K 0.04% 243
2016
Q3 		$1.29M Buy
10,259
+360
+4% +$46.5K 0.03% 267
2016
Q2 		$1.3M Buy
9,899
+528
+6% +$72.2K 0.03% 256
2016
Q1 		$1.3M Sell
9,371
-1,513
-14% -$202K 0.03% 254
2015
Q4 		$1.52M Buy
10,884
+1,281
+13% +$176K 0.04% 232
2015
Q3 		$1.34M Buy
9,603
+271
+3% +$40.7K 0.04% 236
2015
Q2 		$1.53M Sell
9,332
-2,267
-20% -$362K 0.04% 227
2015
Q1 		$1.79M Buy
11,599
+130
+1% +$18.5K 0.04% 275
2014
Q4 		$1.44M Sell
11,469
-6,649
-37% -$822K 0.03% 320
2014
Q3 		$2.17M Sell
18,118
-428
-2% -$49.1K 0.05% 247
2014
Q2 		$2M Sell
18,546
-1,185
-6% -$122K 0.04% 259
2014
Q1 		$1.96M Sell
19,731
-1,891
-9% -$171K 0.04% 254
2013
Q4 		$2M Buy
21,622
+688
+3% +$61.1K 0.04% 251
2013
Q3 		$1.75M Buy
20,934
+797
+4% +$68.3K 0.04% 265
2013
Q2 		$1.65M Buy
+20,137
New +$1.51M 0.04% 275

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Veritable's ELV Position: Q3 2023 in Review

Veritable sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 8,582 shares — an estimated $3.81M sold.

Veritable first reported a position in ELV in Q2 2013 and held it in 41 quarters. The position peaked at $4.97M in Q2 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Veritable reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Veritable sold 8,582 Elevance Health shares in Q3 2023, an estimated $3.81M.
  • Veritable first reported a position in Elevance Health in Q2 2013 and held it in 41 quarters.
  • Veritable's Elevance Health position peaked at $4.97M in Q2 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Veritable's 13F filing for Q3 2023.